Literature DB >> 8638699

Preservation of insulin secretory responses to P2 purinoceptor agonists in Zucker diabetic fatty rats.

J Tang1, W Pugh, K S Polonsky, H Zhang.   

Abstract

The role of P2 purinoceptor agonists in regulatory insulin secretion in Zucker diabetic fatty (ZDF) rats was studied using the isolated perfused pancreas and intracellular Ca2+ concentration ([Ca2+]i) microfluorimetry. The relative potency of different purinoceptor agonists to stimulate the insulin secretory process was consistent with the conclusion that responses in [Ca2+]i and insulin secretion are mediated by the P2y subtype of purinoceptors. Additional studies using specific antagonists of the Ca2+ signaling pathway indicated that activation of P2y purinoceptor releases Ca2+ from intracellular stores and promotes Ca2+ entry through voltage-independent rather than voltage-dependent Ca2+ channels on the beta-cell membrane. Perfused pancreas and isolated islets from ZDF rats demonstrated markedly reduced or absent insulin secretion and [Ca2+]i responses to glucose and KCl. In contrast, responses to P2y purinoceptor agonists were normal, indicating that the secretion coupling pathway activated by these agonists is preserved in glucose-unresponsive islets from diabetic animals. These observations raise the possibility that the purinoceptor pathway may play an important role in regulating insulin secretion in hyperinsulinemic non-insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8638699     DOI: 10.1152/ajpendo.1996.270.3.E504

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Purinergic receptors in the endocrine and exocrine pancreas.

Authors:  I Novak
Journal:  Purinergic Signal       Date:  2007-12-11       Impact factor: 3.765

2.  Expression of NTPDase1 and caveolins in human cardiovascular disease.

Authors:  Agnes Kittel; Anna L Kiss; Nándor Müllner; Ida Matkó; Beáta Sperlágh
Journal:  Histochem Cell Biol       Date:  2005-07-19       Impact factor: 4.304

3.  Iron-mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis.

Authors:  Hani A Jouihan; Paul A Cobine; Robert C Cooksey; Emily A Hoagland; Sihem Boudina; E Dale Abel; Dennis R Winge; Donald A McClain
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

Review 4.  Purinergic signaling in diabetes and metabolism.

Authors:  Shanu Jain; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2020-12-25       Impact factor: 5.858

Review 5.  Purinergic signalling and diabetes.

Authors:  Geoffrey Burnstock; Ivana Novak
Journal:  Purinergic Signal       Date:  2013-04-03       Impact factor: 3.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.